Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1855-1863
Published online before print September 24, 2007, doi: 10.1161/CIRCULATIONAHA.107.186661
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/16/1855    most recent
CIRCULATIONAHA.107.186661v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halperin, H.
Right arrow Articles by Peberdy, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halperin, H.
Right arrow Articles by Peberdy, M. A.
Related Collections
Right arrow Other Ethics and Policy
Right arrow AHA Statements and Guidelines
Right arrow CPR and emergency cardiac care

(Circulation. 2007;116:1855-1863.)
© 2007 American Heart Association, Inc.


AHA Special Report

Recommendations for Implementation of Community Consultation and Public Disclosure Under the Food and Drug Administration’s "Exception From Informed Consent Requirements for Emergency Research"

A Special Report From the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: Endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine

Henry Halperin, MD, MA, FAHA; Norman Paradis, MD; Vincent Mosesso, Jr, MD; Graham Nichol, MD, MPH, FRCPC, FAHA; Michael Sayre, MD; Joseph P. Ornato, MD, FAHA; Michael Gerardi, MD; Vinay M. Nadkarni, MD, FAHA; Robert Berg, MD, FAHA; Lance Becker, MD, FAHA; Mark Siegler, MD; Megan Collins, MD; Charles B. Cairns, MD, FACEP; Michelle H. Biros, MD, MS; Terry Vanden Hoek, MD; Mary Ann Peberdy, MD


Key Words: AHA Scientific Statement • emergency medical services


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
In addition to the usual requirement of appropriate study design and institutional review board (IRB) approval, research studies performed under the Food and Drug Administration (FDA) and Department of Health and Human Services regulations regarding "Informed Consent and Waiver of Informed Consent Requirements in Certain Emergency Research" (21 CFR §50.24)1 require community consultation and public disclosure. This special report discusses the general issues related to consent in emergency circumstances and provides a template to help IRBs implement community consultation and public disclosure appropriately. A portion of the material in this special report was presented as testimony by Dr Halperin on October 11, 2006, at the FDA’s public hearing on "Draft Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors: Exception From Informed Consent Requirements for Emergency Research."

More than 300 000 Americans die each year due to catastrophic medical and surgical emergencies.2,3 New interventions based on sound research could save lives. These research studies must be done within an ethical framework that traditionally includes obtaining prospective informed consent from the research subject. The ethical framework for the conduct of human research began with the development of the Nuremberg Code4,5 in 1949. This code states that (1) informed consent of volunteers must be obtained without coercion of any form, (2) human experiments should be based on prior animal experiments, (3) the anticipated scientific results should justify the experiment, (4) only qualified scientists should conduct medical research, (5) physical and mental suffering should be avoided, and (6) no expectation of death or . . . [Full Text of this Article]


Find additional patient-related information at:

http://www.americanheart.org/presenter.jhtml?identifier=3052016


This article has been cited by other articles:


Home page
NeurologyHome page
M. L. Flaherty, J. Karlawish, J. C. Khoury, D. Kleindorfer, D. Woo, and J. P. Broderick
How important is surrogate consent for stroke research?
Neurology, November 11, 2008; 71(20): 1566 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld
Update in Critical Care 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 808 - 819.
[Full Text] [PDF]